Floatz logo

Cernilton

Chronic Prostatitis

University of GiessenPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Chronic Prostatitis cohort.

Asset / SponsorPhaseRating
Ningmitai
Xintian Pharmaceutical
Phase 4BBB
Tamsulosin
Xintian Pharmaceutical
Phase 4BB
Selenium
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
PALMITIC MONOETHANOLAMIDE
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB
Serenoa repens extract
Clinica Urologica Molinette - Città della Saliute e della Scienza
Phase 4BB

View all 20 →

Same molecule, other indications

Cernilton is also rated in:

Chronic Pelvic Pain SyndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →